Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation

TNF can potentiate IFN-gamma production by activated T cells and other members of the TNF-superfamily play key roles in this effect. A newly discovered TNF-superfamily cytokine (TL1A) could also be involved in initiating or promoting the Th1 response by enhancing IFN-gamma production. The purpose of...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 112(2004), 1 vom: 16. Juli, Seite 66-77
1. Verfasser: Prehn, John L (VerfasserIn)
Weitere Verfasser: Mehdizadeh, Shahab, Landers, Carol J, Luo, Xia, Cha, Stephanie C, Wei, Ping, Targan, Stephan R
Format: Aufsatz
Sprache:English
Veröffentlicht: 2004
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, U.S. Gov't, P.H.S. Receptors, Tumor Necrosis Factor Receptors, Tumor Necrosis Factor, Member 25 TNFRSF25 protein, human TNFSF15 protein, human Tumor Necrosis Factor Ligand Superfamily Member 15 Tumor Necrosis Factor-alpha Interleukin-10 130068-27-8 mehr... Interleukin-4 207137-56-2 RNA 63231-63-0
LEADER 01000naa a22002652 4500
001 NLM148943217
003 DE-627
005 20231223050657.0
007 tu
008 231223s2004 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0497.xml 
035 |a (DE-627)NLM148943217 
035 |a (NLM)15207783 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Prehn, John L  |e verfasserin  |4 aut 
245 1 0 |a Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation 
264 1 |c 2004 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 19.08.2004 
500 |a Date Revised 14.11.2007 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a TNF can potentiate IFN-gamma production by activated T cells and other members of the TNF-superfamily play key roles in this effect. A newly discovered TNF-superfamily cytokine (TL1A) could also be involved in initiating or promoting the Th1 response by enhancing IFN-gamma production. The purpose of this study was to assess the role of recombinant TL1A on IFN-gamma production by cultured PBMC and lamina propria LPMC and to determine whether TL1A expression is altered in inflammatory bowel disease. IFN-gamma, but not IL-4 or IL-10 production by PBMC and LPL, was dose-dependently augmented by TL1A (or by activation of its receptor, death domain receptor 3 [DR3], with specific mAb) independently of, but in synergy with, IL-12 and IL-18. T cell activating stimuli induced expression of TL1A on the cell membrane (mb-TL1A) in a fraction of peripheral blood (PB) T cells. In the intestinal mucosa, a fraction of lamina propria (LP) T cells, especially CD4+ cells, constitutively expressed mb-TL1A, and the fraction increased in mucosal inflammation. A higher fraction of cells also express the TL1A receptor DR3 in ulcerative colitis and Crohn's disease. TL1A transcript was several times more abundant in RNA from mucosal biopsies taken from inflamed Crohn's disease lesions than in those taken from uninvolved areas. Expression of TL1A and its receptor DR3 by lamina propria mononuclear cells (LPMC) could have significant influence on the severity of mucosal inflammation 
650 4 |a Journal Article 
650 4 |a Research Support, U.S. Gov't, P.H.S. 
650 7 |a Receptors, Tumor Necrosis Factor  |2 NLM 
650 7 |a Receptors, Tumor Necrosis Factor, Member 25  |2 NLM 
650 7 |a TNFRSF25 protein, human  |2 NLM 
650 7 |a TNFSF15 protein, human  |2 NLM 
650 7 |a Tumor Necrosis Factor Ligand Superfamily Member 15  |2 NLM 
650 7 |a Tumor Necrosis Factor-alpha  |2 NLM 
650 7 |a Interleukin-10  |2 NLM 
650 7 |a 130068-27-8  |2 NLM 
650 7 |a Interleukin-4  |2 NLM 
650 7 |a 207137-56-2  |2 NLM 
650 7 |a RNA  |2 NLM 
650 7 |a 63231-63-0  |2 NLM 
700 1 |a Mehdizadeh, Shahab  |e verfasserin  |4 aut 
700 1 |a Landers, Carol J  |e verfasserin  |4 aut 
700 1 |a Luo, Xia  |e verfasserin  |4 aut 
700 1 |a Cha, Stephanie C  |e verfasserin  |4 aut 
700 1 |a Wei, Ping  |e verfasserin  |4 aut 
700 1 |a Targan, Stephan R  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 112(2004), 1 vom: 16. Juli, Seite 66-77  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:112  |g year:2004  |g number:1  |g day:16  |g month:07  |g pages:66-77 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 112  |j 2004  |e 1  |b 16  |c 07  |h 66-77